Trademarkia Logo

Canada

C$
Trademark Search in Canada
A2 BIO

View On IC.GC.CA

A2 BIO
FORMALIZED

on 3 Jul 2024

Last Applicant/ Owned by

A2 Biotherapeutics, Inc.

30301 Agoura Road, Suite 210Agoura Hills CA 91301

US

Serial Number

2336209 filed on 11th Aug 2023

Correspondent Address

GOWLING WLG (CANADA) LLP

550 BURRARD STREETSUITE 2300VANCOUVER

BRITISH COLUMBIA

CA

V6C2B5

A2 BIO

Trademark usage description

therapeutics in the nature of cells, proteins and protein complexes for the treatment and prevention of cancer, inflammation, and inflammatory disease Read More

Classification Information

Class [005]
Therapeutics in the nature of cells, proteins and protein complexes for the treatment and prevention of cancer, inflammation, and inflammatory diseases; biotherapeutics for the treatment and prevention of cancer, inflammation, and inflammatory diseases; medicines; pharmaceuticals; pharmaceutical products for the treatment and prevention of cancer and inflammatory diseases; therapeutic targets, namely, proteins or protein complexes, for the treatment and prevention of cancer, inflammation and inflammatory diseases; therapeutic cells, therapeutic proteins and therapeutic antibodies for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; therapeutics and cell therapies in the nature of cells, proteins and protein complexes for the treatment of cancer, inflammation, and inflammatory diseases; engineered cell therapies in the nature of cells, proteins and protein complexes for medical purposes, namely, the treatment and prevention of cancer, inflammation and inflammatory diseases; engineered cell therapy platforms consisting of modified cells, cell receptors, proteins and protein complexes; cell platforms consisting of modified cells, cell receptors, proteins and protein complexes for the treatment and prevention of cancer, inflammation and inflammatory diseases; technology cell platforms for developing and engineering therapeutic cells, therapeutic proteins, therapeutic antibodies, therapeutics and cellular therapies for the treatment and prevention of cancer, inflammation, and inflammatory diseases; cell platform for autologous and allogeneic cell manufacturing; therapeutics in the nature of cells, proteins and protein complexes and cell therapies targeting targets lost in tumors for the treatment and prevention of cancer, inflammation and inflammatory diseases; gene therapy products, namely, genetically engineered tissues for transplant purposes.

Classification kind code

12

Class [040]
Custom manufacturing of therapeutics, biotherapeutics, medicines, and pharmaceuticals; manufacturing of cells, therapeutics and cell therapies for the treatment and prevention of cancer, inflammation and inflammatory diseases; biomanufacturing for others; cell therapy manufacturing for others; autologous and allogeneic cell manufacturing for others; manufacturing services for others in the fields of therapeutics, cell therapies, biologics, medicine, and pharmaceuticals; providing technical information in the field of pharmaceutical manufacturing; custom manufacturing of biological cells, cellular targets, proteins, and antibodies for others for treatment and prevention of cancer, inflammation and inflammatory disease.

Classification kind code

12

Class [042]
Medical research services; pharmaceutical and biopharmaceutical research and development services; identification and development of therapeutic targets for others for the treatment and prevention of cancer, inflammation and inflammatory diseases; development of therapeutics and cell therapies for treatment and prevention of cancer, inflammation, and inflammatory diseases; identification and development of therapeutic targets for others for the treatment and prevention of cancer, inflammation and inflammatory diseases; biotechnology research, development, testing and analysis for the treatment of cancer, inflammation, and inflammatory diseases; scientific research and development services; medical laboratory services, namely, tissue material processing and analysis in the field of autologous and allogeneic biologic preparations for medical use; biotechnology laboratory services; scientific and medical laboratory services; genetic engineering services; engineering of biological cells, cellular targets, proteins, and antibodies for others; provision of medical and scientific research information in the fields of therapeutics, biotherapeutics, medicines, pharmaceuticals; providing scientific information relating to treatment and prevention of cancer, inflammation and inflammatory diseases; medical and scientific research, development, engineering and testing services in the fields of therapeutics, cell therapies, biologics, medicine, and pharmaceuticals.

Classification kind code

12

Mark Details

Serial Number

2336209

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 48
on 23rd May 2025		Agent Changed
Submitted for opposition 256
on 5th May 2025		Notification of Possible Opposition Sent
Submitted for opposition 257
on 4th Jul 2024		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 3rd Jul 2024		Created
Submitted for opposition 31
on 3rd Jul 2024		Formalized
Submitted for opposition 30
on 11th Aug 2023		Filed
Submitted for opposition 228
on 11th Aug 2023		International Registration